Literature DB >> 8254052

Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.

U Beuers1, M H Nathanson, C M Isales, J L Boyer.   

Abstract

To assess the effects of tauroursodeoxycholic acid (TUDCA) on bile excretory function, we examined whether TUDCA modulates vesicular exocytosis in the isolated perfused liver of normal rats in the presence of high (1.9 mM) or low (0.19 mM) extracellular Ca++ and in cholestatic rats 24 h after bile duct ligation. In addition, the effects of TUDCA on Ca++ homeostasis were compared in normal and in cholestatic hepatocytes. In the isolated perfused rat liver, TUDCA (25 microM) stimulated a sustained increase in the biliary excretion of horseradish peroxidase, a marker of the vesicular pathway, in the presence of high, but not low extracellular Ca++ or in the cholestatic liver. In contrast, TUDCA stimulated bile flow to the same extent regardless of the concentration of extracellular Ca++ or the presence of cholestasis. In indo-1-loaded hepatocytes, basal cytosolic free Ca++ ([Ca++]i) levels were not different between normal and cholestatic cells. However, in cholestatic cells [Ca++]i increases induced by TUDCA (10 microM) and its 7 alpha-OH epimer taurochenodeoxycholic acid (50 microM) were reduced to 22% and 26%, respectively, compared to normal cells. The impairment of TUDCA-induced [Ca++]i increase in cholestatic cells could be mimicked by exposing normal cells to low extracellular Ca++ (21%) or to the Ca++ channel blocker NiCl2 (23%). These data indicate that (a) dihydroxy bile acid-induced Ca++ entry may be of functional importance in the regulation of hepatocellular vesicular exocytosis, and (b) this Ca++ entry mechanism across the plasma membrane is impaired in cholestatic hepatocytes. We speculate that the beneficial effect of ursodeoxycholic acid in cholestatic liver diseases may be related to the Ca+(+)-dependent stimulation of vesicular exocytosis by its conjugate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254052      PMCID: PMC288502          DOI: 10.1172/JCI116921

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Role of the hepatocyte microtubular system in the excretion of bile salts and biliary lipid: implications for intracellular vesicular transport.

Authors:  J M Crawford; C A Berken; J L Gollan
Journal:  J Lipid Res       Date:  1988-02       Impact factor: 5.922

2.  Isolated rat hepatocyte couplets in short-term culture: structural characteristics and plasma membrane reorganization.

Authors:  A Gautam; O C Ng; J L Boyer
Journal:  Hepatology       Date:  1987 Mar-Apr       Impact factor: 17.425

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  Characterization of calcium deprivation-induced cholestasis in the perfused rat liver.

Authors:  J Reichen; F Berr; M Le; G H Warren
Journal:  Am J Physiol       Date:  1985-07

5.  Thyrotropin-releasing hormone-induced spike and plateau in cytosolic free Ca2+ concentrations in pituitary cells. Relation to prolactin release.

Authors:  P R Albert; A H Tashjian
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

6.  Noradrenaline, vasopressin and angiotensin increase Ca2+ influx by opening a common pool of Ca2+ channels in isolated rat liver cells.

Authors:  J P Mauger; J Poggioli; F Guesdon; M Claret
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

7.  Role of extracellular Ca2+ in hepatic bile formation and taurocholate transport.

Authors:  M S Anwer; L M Clayton
Journal:  Am J Physiol       Date:  1985-12

8.  Bile secretory apparatus: evidence for a vesicular transport mechanism for proteins in the rat, using horseradish peroxidase and [125I]insulin.

Authors:  R H Renston; D G Maloney; A L Jones; G T Hradek; K Y Wong; I D Goldfine
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

9.  Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors:  R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

10.  Transcytosis and paracellular movements of horseradish peroxidase across liver parenchymal tissue from blood to bile. Effects of alpha-naphthylisothiocyanate and colchicine.

Authors:  P J Lowe; K S Kan; S G Barnwell; R K Sharma; R Coleman
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

View more
  34 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.

Authors:  Marco Marzioni; Heather Francis; Antonio Benedetti; Yoshiyuki Ueno; Giammarco Fava; Juliet Venter; Ramona Reichenbach; Maria Grazia Mancino; Ryun Summers; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 3.  Calcium signaling in the liver.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 4.  Novel therapeutic targets in primary biliary cirrhosis.

Authors:  Jessica K Dyson; Gideon M Hirschfield; David H Adams; Ulrich Beuers; Derek A Mann; Keith D Lindor; David E J Jones
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

Review 5.  Bile secretion--models, mechanisms, and malfunctions. A perspective on the development of modern cellular and molecular concepts of bile secretion and cholestasis.

Authors:  J L Boyer
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

6.  Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.

Authors:  Simon Hohenester; Anna Gates; Ralf Wimmer; Ulrich Beuers; M Sawkat Anwer; Christian Rust; Cynthia R L Webster
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

Review 7.  Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?

Authors:  Kyle R Gronbeck; Cecilia M P Rodrigues; Javad Mahmoudi; Eric M Bershad; Geoffrey Ling; Salam P Bachour; Afshin A Divani
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

8.  Bile salts stimulate mucin secretion by cultured dog gallbladder epithelial cells independent of their detergent effect.

Authors:  J H Klinkspoor; T Yoshida; S P Lee
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

9.  Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization.

Authors:  T Ono; K Imai; H Kohno; M Uchida; Y Takemoto; D K Dhar; N Nagasue
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.